<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-27892" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Prothrombin Time</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Yang</surname>
            <given-names>Rocky</given-names>
          </name>
          <aff>American University/ Kern Medical</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zubair</surname>
            <given-names>Muhammad</given-names>
          </name>
          <aff>Indus Hospital &#x00026; Health Network</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Moosavi</surname>
            <given-names>Leila</given-names>
          </name>
          <aff>Kern Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rocky Yang declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Zubair declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Leila Moosavi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>23</day>
          <month>1</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-27892.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Prothrombin time is one of several blood tests routinely used in clinical practice to evaluate the coagulation status of patients. More specifically, prothrombin time is used to evaluate the extrinsic and common pathways of coagulation, which helps detect deficiencies of factors II, V, VII, and X and low fibrinogen concentrations.<xref ref-type="bibr" rid="article-27892.r1">[1]</xref><xref ref-type="bibr" rid="article-27892.r2">[2]</xref>&#x000a0;Prothrombin time measures the time, in seconds, for plasma to clot after adding thromboplastin (a mixture of tissue factor, calcium, and phospholipid) to a patient's plasma sample.<xref ref-type="bibr" rid="article-27892.r1">[1]</xref></p>
        <p>Different preparations of thromboplastin reagents are available but can give different prothrombin time results even when using the same plasma. Due to this variability, the World Health Organization (WHO) introduced the international normalized ratio (INR), the standard reporting format for prothrombin time results.<xref ref-type="bibr" rid="article-27892.r3">[3]</xref><xref ref-type="bibr" rid="article-27892.r4">[4]</xref>&#x000a0;The INR represents the ratio of the patient's prothrombin time divided by a control prothrombin time value obtained using an international reference thromboplastin reagent developed by the WHO.<xref ref-type="bibr" rid="article-27892.r1">[1]</xref></p>
        <p>Standard laboratory coagulation-based testing has traditionally been used to obtain measurements of prothrombin time to ensure reliable results. Due to the high turnaround time (up to 90 minutes), point-of-care (POC) devices (approximately 5 minutes) are becoming more desirable.<xref ref-type="bibr" rid="article-27892.r5">[5]</xref>&#x000a0;POC devices are of great value in emergency and operating room settings where clinical diagnosis and intervention are time-sensitive.<xref ref-type="bibr" rid="article-27892.r6">[6]</xref>&#x000a0;</p>
        <p>With increased prescribing of vitamin K-antagonists like warfarin, point-of-care devices have also been more convenient for patients and clinicians to monitor medication effectiveness. With point-of-care devices, monitoring anticoagulation therapy can take place at thrombosis centers, primary care provider offices, and even by the patients themselves.<xref ref-type="bibr" rid="article-27892.r4">[4]</xref>&#x000a0;Although point-of-care devices have been shown to underestimate hemostatic abnormality, point-of-care devices are generally reliable in non-emergency settings.<xref ref-type="bibr" rid="article-27892.r7">[7]</xref></p>
      </sec>
      <sec id="article-27892.s2" sec-type="Specimen Collection">
        <title>Specimen Collection</title>
        <p>Test results are dependent on the specimen quality. Specimens and request slips must be labeled with the patient&#x02019;s name, medical record number or date of birth, collection date, and specimen source, when applicable.<xref ref-type="bibr" rid="article-27892.r8">[8]</xref>&#x000a0;Coagulation tests must be performed using plasma samples, not serum, as clotting factors are removed in serum preparations. Standard percutaneous phlebotomy is the recommended method used to collect venous blood samples. However, blood samples may also be obtained from indwelling intravenous lines when necessary.<xref ref-type="bibr" rid="article-27892.r9">[9]</xref></p>
        <p>Phlebotomists collect venous blood samples in plastic tubes with a light blue top that contains 3.2% sodium citrate.<xref ref-type="bibr" rid="article-27892.r10">[10]</xref>&#x000a0;Sodium citrate chelates the calcium in the blood sample and prevents the activation of the coagulation cascade.<xref ref-type="bibr" rid="article-27892.r11">[11]</xref>&#x000a0;This chelation keeps the blood sample in stasis until it is ready to be tested. Tube filling must be within 90% of the full collection volume with a blood-to-sodium citrate ratio of 9 to 1.<xref ref-type="bibr" rid="article-27892.r7">[7]</xref>&#x000a0;The tube is then gently inverted a few times to mix the sodium citrate solution with the blood. The tube should not be shaken to avoid hemolysis, which would lead to inaccurate results. Once the blood sample is ready to be tested, calcium chloride is added to restore the calcium required for coagulation activation.<xref ref-type="bibr" rid="article-27892.r11">[11]</xref>&#x000a0;Clot formation can be detected mechanically or optically, depending on the instrumentation used.<xref ref-type="bibr" rid="article-27892.r12">[12]</xref></p>
      </sec>
      <sec id="article-27892.s3" sec-type="Procedures">
        <title>Procedures</title>
        <p>Clot-based tests (eg, prothrombin time/INR, aPTT, and TT) detect the time interval from initiation of coagulation to clot formation. Detection of clot formation as an endpoint has been accomplished in several ways.<xref ref-type="bibr" rid="article-27892.r13">[13]</xref>&#x000a0;Early methods used a tilt-tube technique that depended on visually identifying clot formation in plasma samples. A water bath was necessary to keep the temperature at 37 &#x000b0;C. Currently, this time-intensive manual method is used only with international reference thromboplastins.<xref ref-type="bibr" rid="article-27892.r14">[14]</xref></p>
        <p>As a result of high-volume testing, most coagulation testing is now performed on automated instruments that control the reaction&#x02019;s temperature and detect endpoints using several methods. Most methods detect changes in physical/mechanical properties or the light transmission produced by polymerized fibrin.<xref ref-type="bibr" rid="article-27892.r15">[15]</xref>&#x000a0;Numerous approaches for mechanical endpoint detection have been developed. One mechanical method consists of a metal ball at the bottom of a sample cuvette sent into a back-and-forth motion by a magnet; the endpoint is detected when fibrin monomers polymerize into fibrin strands and impede the ball&#x02019;s motion. Another mechanical detection system uses a magnet to hold a ball to the side of a rotating cuvette until fibrin strands physically displace the ball.<xref ref-type="bibr" rid="article-27892.r16">[16]</xref>&#x000a0;Optical methods (usually nephelometric but occasionally turbidimetric) use decreased&#x000a0;light transmission or increased light scatter as fibrin monomers are polymerized into fibrin strands.<xref ref-type="bibr" rid="article-27892.r17">[17]</xref><xref ref-type="bibr" rid="article-27892.r18">[18]</xref></p>
        <p>Optical endpoints may occur at preset thresholds or use the kinetics, such as maximum acceleration of fibrin polymerization, to define endpoints. Light sources have traditionally been halogen lamps or lasers, but newer instruments may use light-emitting diodes that increase longevity and allow measurement at wavelengths that overlap less with interfering substances.<xref ref-type="bibr" rid="article-27892.r19">[19]</xref>&#x000a0;A potential advantage of mechanical over optical endpoint detection is reduced interference from substances that interfere with optical methods, such as hemoglobin, bilirubin, or lipids.<xref ref-type="bibr" rid="article-27892.r20">[20]</xref></p>
        <p>As for any laboratory investigation, the accuracy of prothrombin time and advanced partial thromboplastin (aPTT) results must be monitored regularly using quality control materials.<xref ref-type="bibr" rid="article-27892.r21">[21]</xref>&#x000a0;The analytical examination process&#x02019;s quality control (QC) monitors a measurement procedure to verify that it meets performance specifications appropriate for patient care or that an error condition must be corrected.<xref ref-type="bibr" rid="article-27892.r22">[22]</xref>&#x000a0;Automated hematology and coagulation test systems require 2 levels of controls every 8 hours of testing and each time a change in reagent occurs. If necessary, laboratories can assay QC samples more frequently to ensure accurate results.<xref ref-type="bibr" rid="article-27892.r23">[23]</xref>&#x000a0;For manual coagulation testing, each analyst must perform 2 levels of controls before testing patient samples and with each change in the reagent. In addition, patient and control samples must be tested in duplicate.<xref ref-type="bibr" rid="article-27892.r24">[24]</xref></p>
        <p>The quality control for prothrombin time and aPTT testing may be assayed or unassayed.<xref ref-type="bibr" rid="article-27892.r25">[25]</xref>&#x000a0;Quality control that is deemed to be &#x02018;assayed&#x02019; is supplied with target values. The target values assigned to a control are specific to the reagent and analyzer used to generate the test result. Ensure the correct target range is used. Unassayed control does not have target values assigned. If a laboratory chooses to use unassayed control, they must know they need to&#x000a0;generate their target ranges.<xref ref-type="bibr" rid="article-27892.r26">[26]</xref></p>
        <p>The acceptable range and rules for interpreting QC results are based on the probability of detecting a significant analytical error condition with an acceptably low false alert rate.<xref ref-type="bibr" rid="article-27892.r27">[27]</xref>&#x000a0;The desired process control performance characteristics must be established for each measurement before selecting the appropriate QC rules.<xref ref-type="bibr" rid="article-27892.r28">[28]</xref>&#x000a0;Westgard multi-rules are normally used to evaluate the quality control runs. If a run is declared out of control, the system is investigated (instrument, standards, controls, etc) to determine the cause of the problem. No analysis is performed until the issue has been resolved.<xref ref-type="bibr" rid="article-27892.r28">[28]</xref></p>
        <p>Changing reagent lots can have an unexpected impact on QC results. Careful reagent lot crossover evaluation of QC target values is necessary. Because the matrix-related interaction between a QC material and a reagent can change with a different reagent lot, QC results may not be a reliable indicator of a measurement procedure&#x02019;s performance for patient samples after a reagent lot change.<xref ref-type="bibr" rid="article-27892.r29">[29]</xref>&#x000a0;Use clinical patient samples to verify the consistency of results between old and new lots of reagents because of the unpredictability of a matrix-related bias being present for QC materials.<xref ref-type="bibr" rid="article-27892.r30">[30]</xref></p>
        <p>The laboratory must participate in the external quality control or proficiency testing program because it is a regulatory requirement published by the Centers for Medicare and Medicaid Services (CMS) in the Clinical Laboratory Improvement Amendments regulations.<xref ref-type="bibr" rid="article-27892.r31">[31]</xref>&#x000a0;Ensuring the accuracy and reliability of the laboratory concerning other laboratories performing the same or comparable assays is helpful.<xref ref-type="bibr" rid="article-27892.r32">[32]</xref>&#x000a0;Required participation and scored CMS and voluntary accreditation organizations monitor results. The proficiency testing plan should be included in&#x000a0;the quality QA plan and the laboratory's overall quality program.<xref ref-type="bibr" rid="article-27892.r33">[33]</xref></p>
      </sec>
      <sec id="article-27892.s4" sec-type="Indications">
        <title>Indications</title>
        <p>Indications for obtaining prothrombin time are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Monitoring vitamin K-antagonists such as warfarin is the most common indication of prothrombin time</p>
          </list-item>
          <list-item>
            <p>Evaluation of unexplained bleeding</p>
          </list-item>
          <list-item>
            <p>Diagnosing disseminated intravascular coagulation&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Obtaining baseline value before initiating anticoagulation therapy</p>
          </list-item>
          <list-item>
            <p>Assessment of liver synthesis function and calculation of the model for end-stage liver disease score in liver disease&#x000a0;<xref ref-type="bibr" rid="article-27892.r10">[10]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27892.s5" sec-type="Potential Diagnosis">
        <title>Potential Diagnosis</title>
        <p>Causes for a prolonged prothrombin time include:</p>
        <p><bold>Liver Disease:&#x000a0;</bold>Liver disease or liver dysfunction decreases the production of most coagulation factors. A decreased production of coagulation factors leads to prolonged prothrombin time and physical manifestations that can include petechiae and easy bruising.<xref ref-type="bibr" rid="article-27892.r4">[4]</xref></p>
        <p><bold>Vitamin K Deficiency:&#x000a0;</bold>Vitamin K is essential for the synthesis of coagulation factors II, VII, IX, and X. A deficiency in vitamin K will decrease these factors and prolong prothrombin time. Potential causes that can lead to decreased vitamin K levels include malnutrition, prolonged antibiotic use, and impairments in fat absorption.<xref ref-type="bibr" rid="article-27892.r10">[10]</xref></p>
        <p><bold>Factor Deficiency:&#x000a0;</bold>Inherited diseases that decrease the production of factors II, V, IX, and X will lead to prolonged prothrombin time.</p>
        <p><bold>Disseminated Intravascular Coagulation:&#x000a0;</bold>Disseminated intravascular coagulation causes a system-wide activation of coagulation, depleting available coagulation factors and increasing prothrombin time.</p>
        <p><bold>Vitamin K&#x02013;Antagonist Therapy:&#x000a0;</bold>Vitamin K-antagonist therapy inhibits factors II, VII, IX, and X and causes prolonged prothrombin time.</p>
        <p><bold>Antiphospholipid Antibodies:&#x000a0;</bold>Antiphospholipid antibody syndrome characteristically presents with recurrent thromboembolic events or pregnancy loss along with detected antiphospholipid antibodies (APA).<xref ref-type="bibr" rid="article-27892.r34">[34]</xref>&#x000a0;APA causes an increased conversion of prothrombin to thrombin in vivo, leading to an overall decrease in prothrombin. Low prothrombin levels can lead to an increased prothrombin time result.<xref ref-type="bibr" rid="article-27892.r35">[35]</xref></p>
      </sec>
      <sec id="article-27892.s6" sec-type="Normal and Critical Findings">
        <title>Normal and Critical Findings</title>
        <p>The reference ranges for prothrombin time vary by laboratory since different facilities use reagents or instruments. In most laboratories, the normal range for prothrombin time is 10 to 13 seconds.<xref ref-type="bibr" rid="article-27892.r11">[11]</xref>&#x000a0;The normal INR for a healthy individual is 1.1 or below, and the therapeutic range for most patients on VKAs is an INR of 2 to 3.<xref ref-type="bibr" rid="article-27892.r4">[4]</xref>&#x000a0;An increased prothrombin time/INR for patients on VKAs may suggest a super-therapeutic level and will require medication dose adjustments to prevent bleeding.<xref ref-type="bibr" rid="article-27892.r36">[36]</xref>&#x000a0;The sensitivity of prothrombin time reagents to the deficiency of coagulation factors varies with the specific reagent and instrument combination. Therefore, it is useful for laboratories to determine the sensitivity of a given prothrombin time system to factors VII, X, V, and II.<xref ref-type="bibr" rid="article-27892.r37">[37]</xref></p>
      </sec>
      <sec id="article-27892.s7" sec-type="Interfering Factors">
        <title>Interfering Factors</title>
        <p>Control of preanalytical issues in coagulation testing is paramount for good laboratory performance. In addition to the common problems of hemolyzed, icteric, or lipemic samples, some preanalytical factors of particular importance in coagulation testing include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Clotted specimens</p>
          </list-item>
          <list-item>
            <p>Improper blood-to-anticoagulant ratio</p>
          </list-item>
          <list-item>
            <p>Contamination with saline, heparin, or other anticoagulants&#x000a0;<xref ref-type="bibr" rid="article-27892.r38">[38]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>Traumatic venipuncture, activation of coagulation within the collection device, or improper mixing of the anticoagulant with blood may result in clotting, which consumes coagulation factors, making testing unreliable.<xref ref-type="bibr" rid="article-27892.r39">[39]</xref></p>
        <p>Blood is commonly collected into commercially available tubes with pre-aliquoted trisodium citrate and a line indicating the appropriate volume of blood to be drawn. Blood volume collection less than the recommended volume (&#x0201c;a short draw&#x0201d;) will result in excess anticoagulant compared to plasma and prolonged clotting times.<xref ref-type="bibr" rid="article-27892.r40">[40]</xref>&#x000a0;Plasma should be stored at room temperature for prothrombin time but may be stored at either room or refrigerated temperatures (2 to 8 &#x000b0;C) for aPTT.<xref ref-type="bibr" rid="article-27892.r38">[38]</xref></p>
        <p>Whole-blood samples should be stored at 18 to 24 &#x000b0;C, whereas refrigerated temperatures should be avoided because of possible &#x0201c;cold activation&#x0201d; of factor VII.<xref ref-type="bibr" rid="article-27892.r39">[39]</xref>&#x000a0;Refrigeration of whole blood also decreases factor VIII and VWF and may cause the misdiagnosis of hemophilia A or&#x000a0;von Willebrand disease.&#x000a0;Cold storage may be acceptable for tests other than prothrombin time if the sample is centrifuged and the plasma is aliquoted.<xref ref-type="bibr" rid="article-27892.r40">[40]</xref>&#x000a0;Samples for monitoring unfractionated heparin therapy should be centrifuged within 1 hour to avoid neutralizing heparin by platelet factor 4 released from platelets.<xref ref-type="bibr" rid="article-27892.r41">[41]</xref>&#x000a0;Frozen samples should be rapidly defrosted at 37 &#x000b0;C and mixed to resuspend any coagulation protein precipitate.<xref ref-type="bibr" rid="article-27892.r42">[42]</xref>&#x000a0;Other influencing factors that affect the coagulation test include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Samples obtained from indwelling catheters may suffer contamination as these lines often require a flush with heparin or other solutions that would artificially prolong coagulation times.<xref ref-type="bibr" rid="article-27892.r9">[9]</xref></p>
          </list-item>
          <list-item>
            <p>Anticoagulants: All direct-acting anticoagulants prolong&#x000a0;prothrombin time <xref ref-type="bibr" rid="article-27892.r43">[43]</xref></p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Argatroban&#x000a0;</p>
              </list-item>
              <list-item>
                <p>Dabigatran</p>
              </list-item>
              <list-item>
                <p>Rivaroxaban</p>
              </list-item>
              <list-item>
                <p>Apixaban</p>
              </list-item>
              <list-item>
                <p>Edoxaban</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Storage and temperature</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Blood samples for prothrombin time testing are only acceptable if stored for less than 24 hours at either room temperature or 4 &#x000b0;C.<xref ref-type="bibr" rid="article-27892.r1">[1]</xref></p>
              </list-item>
              <list-item>
                <p>Prolonged cold storage at 4 degrees Celsius or lower can activate Factor VII, leading to shortened prothrombin time results.<xref ref-type="bibr" rid="article-27892.r11">[11]</xref></p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>High lipid levels</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Patients with hypercholesterolemia or hypertriglyceridemia have a shorter prothrombin time measurement due to elevated fibrinogen and factor VII levels.<xref ref-type="bibr" rid="article-27892.r44">[44]</xref></p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Polycythemia with a hematocrit greater than 55%&#x000a0;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK544269/">[11]</ext-link></p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Hematocrit levels above 55% lead to a decrease in the plasma of the blood sample, thereby reducing the coagulating factors available. Sodium citrate levels must be readjusted for decreased plasma to prevent artificially prolonged prothrombin time measurements.</p>
              </list-item>
            </list>
          </list-item>
        </list>
      </sec>
      <sec id="article-27892.s8" sec-type="Complications">
        <title>Complications</title>
        <p>Some complications of prothrombin time can include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Standard percutaneous phlebotomy to obtain blood samples can cause localized pain, bleeding, and bruising.</p>
          </list-item>
          <list-item>
            <p>A decreased prothrombin time/INR suggests:</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Increased intake of supplements that contain vitamin K</p>
              </list-item>
              <list-item>
                <p>High intake of vitamin K-rich foods&#x000a0;<xref ref-type="bibr" rid="article-27892.r7">[7]</xref><xref ref-type="bibr" rid="article-27892.r1">[1]</xref></p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Fasting may reduce factors II, VII, and X, subsequently increasing&#x000a0;prothrombin time <xref ref-type="bibr" rid="article-27892.r7">[7]</xref><xref ref-type="bibr" rid="article-27892.r1">[1]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27892.s9" sec-type="Patient Safety and Education">
        <title>Patient Safety and Education</title>
        <p>As the use of vitamin K antagonists increases, it is vital to educate patients on the importance of routine monitoring of prothrombin time/INR. Proper monitoring will allow for medication adjustments and the prevention of adverse events. If patients are self-monitoring with point-of-care testing (POCT) devices, sufficient education and training are necessary for the patient or family members who will assist the patient. Patients&#x02019; cognitive capacity must also be evaluated to ensure the proper use of POCT devices.<xref ref-type="bibr" rid="article-27892.r4">[4]</xref></p>
      </sec>
      <sec id="article-27892.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>The prothrombin time and INR are important measurements to monitor patient coagulation status, especially for patients on vitamin K antagonists. However, although prothrombin time/INR is useful in monitoring coagulation status, they are rarely used alone. Prothrombin time/INR use is typically in conjunction with activated partial thromboplastin time, which evaluates coagulation&#x02019;s intrinsic and common pathways. Prothrombin time/INR and activated partial thromboplastin time results help diagnose various hematologic disorders.</p>
      </sec>
      <sec id="article-27892.s11">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27892&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27892">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/27892/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=27892">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-27892.s12">
        <title>References</title>
        <ref id="article-27892.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levy</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Szlam</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wolberg</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Winkler</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing.</article-title>
            <source>Clin Lab Med</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>453</fpage>
            <page-range>453-77</page-range>
            <pub-id pub-id-type="pmid">25168937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Triplett</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Coagulation and bleeding disorders: review and update.</article-title>
            <source>Clin Chem</source>
            <year>2000</year>
            <month>Aug</month>
            <volume>46</volume>
            <issue>8 Pt 2</issue>
            <fpage>1260</fpage>
            <page-range>1260-9</page-range>
            <pub-id pub-id-type="pmid">10926920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van den Besselaar</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Chantarangkul</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tripodi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Thromboplastin standards.</article-title>
            <source>Biologicals</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>38</volume>
            <issue>4</issue>
            <fpage>430</fpage>
            <page-range>430-6</page-range>
            <pub-id pub-id-type="pmid">20338779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barcellona</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fenu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Marongiu</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Point-of-care testing INR: an overview.</article-title>
            <source>Clin Chem Lab Med</source>
            <year>2017</year>
            <month>May</month>
            <day>01</day>
            <volume>55</volume>
            <issue>6</issue>
            <fpage>800</fpage>
            <page-range>800-805</page-range>
            <pub-id pub-id-type="pmid">27754958</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stein</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kaserer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Spahn</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Spahn</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Point-of-Care Coagulation Monitoring in Trauma Patients.</article-title>
            <source>Semin Thromb Hemost</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>43</volume>
            <issue>4</issue>
            <fpage>367</fpage>
            <page-range>367-374</page-range>
            <pub-id pub-id-type="pmid">28297730</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ebner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Birschmann</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Peter</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>H&#x000e4;rtig</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kuhn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Blumenstock</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zuern</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Ziemann</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Poli</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants.</article-title>
            <source>Crit Care</source>
            <year>2017</year>
            <month>Feb</month>
            <day>15</day>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>32</fpage>
            <pub-id pub-id-type="pmid">28196509</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bolliger</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Point-of-Care Coagulation Testing in Cardiac Surgery.</article-title>
            <source>Semin Thromb Hemost</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>43</volume>
            <issue>4</issue>
            <fpage>386</fpage>
            <page-range>386-396</page-range>
            <pub-id pub-id-type="pmid">28359133</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Magnette</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chatelain</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chatelain</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ten Cate</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mullier</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories.</article-title>
            <source>Thromb J</source>
            <year>2016</year>
            <volume>14</volume>
            <fpage>49</fpage>
            <pub-id pub-id-type="pmid">27999475</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hinds</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Quargnenti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gattuso</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kumar Srivastova</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Penn</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>West</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Cathey</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hawkins</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wilimas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Starr</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Head</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Comparing the results of coagulation tests on blood drawn by venipuncture and through heparinized tunneled venous access devices in pediatric patients with cancer.</article-title>
            <source>Oncol Nurs Forum</source>
            <year>2002</year>
            <month>Apr</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>E26</fpage>
            <page-range>E26-34</page-range>
            <pub-id pub-id-type="pmid">11979291</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kamal</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Tefferi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pruthi</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2007</year>
            <month>Jul</month>
            <volume>82</volume>
            <issue>7</issue>
            <fpage>864</fpage>
            <page-range>864-73</page-range>
            <pub-id pub-id-type="pmid">17605969</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Winter</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Flax</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>NS</given-names>
              </name>
            </person-group>
            <article-title>Coagulation Testing in the Core Laboratory.</article-title>
            <source>Lab Med</source>
            <year>2017</year>
            <month>Nov</month>
            <day>08</day>
            <volume>48</volume>
            <issue>4</issue>
            <fpage>295</fpage>
            <page-range>295-313</page-range>
            <pub-id pub-id-type="pmid">29126301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lippi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Plebani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Favaloro</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Interference in coagulation testing: focus on spurious hemolysis, icterus, and lipemia.</article-title>
            <source>Semin Thromb Hemost</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>39</volume>
            <issue>3</issue>
            <fpage>258</fpage>
            <page-range>258-66</page-range>
            <pub-id pub-id-type="pmid">23229354</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Opartkiattikul</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Standardization of coagulation tests.</article-title>
            <source>Southeast Asian J Trop Med Public Health</source>
            <year>1999</year>
            <volume>30 Suppl 3</volume>
            <fpage>79</fpage>
            <page-range>79-85</page-range>
            <pub-id pub-id-type="pmid">10926265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kagawa</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>[Prothrombin time and its standardization].</article-title>
            <source>Rinsho Byori</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>50</volume>
            <issue>8</issue>
            <fpage>779</fpage>
            <page-range>779-85</page-range>
            <pub-id pub-id-type="pmid">12373814</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scherer-Buri&#x00107;</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Lesser-Wetzold</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nagel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Weigand</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Spannagl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Teupser</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bruegel</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Performance testing of four automated coagulation analyzers in a university hospital setting with focus on global coagulation assays.</article-title>
            <source>Int J Lab Hematol</source>
            <year>2022</year>
            <month>Jun</month>
            <volume>44</volume>
            <issue>3</issue>
            <fpage>643</fpage>
            <page-range>643-653</page-range>
            <pub-id pub-id-type="pmid">35179298</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lim</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Donnan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nandurkar</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Global coagulation assays in hypercoagulable states.</article-title>
            <source>J Thromb Thrombolysis</source>
            <year>2022</year>
            <month>Jul</month>
            <volume>54</volume>
            <issue>1</issue>
            <fpage>132</fpage>
            <page-range>132-144</page-range>
            <pub-id pub-id-type="pmid">34997471</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huber</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>M&#x000e9;ndez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brunner-Agten</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Automation in haemostasis.</article-title>
            <source>Hamostaseologie</source>
            <year>2013</year>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>295</fpage>
            <page-range>295-8</page-range>
            <pub-id pub-id-type="pmid">23460141</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aggarwal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nayak</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Manohar</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Discrepancy in optical &#x00026; mechanical method in coagulation tests in a turbid sample.</article-title>
            <source>Indian J Hematol Blood Transfus</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>30</volume>
            <issue>Suppl 1</issue>
            <fpage>402</fpage>
            <page-range>402-4</page-range>
            <pub-id pub-id-type="pmid">25332631</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tekkesin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>K&#x00131;l&#x00131;nc</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Optical and mechanical clot detection methodologies: a comparison study for routine coagulation testing.</article-title>
            <source>J Clin Lab Anal</source>
            <year>2012</year>
            <month>May</month>
            <volume>26</volume>
            <issue>3</issue>
            <fpage>125</fpage>
            <page-range>125-9</page-range>
            <pub-id pub-id-type="pmid">22628225</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bai</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Christie</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Gorman</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Comparison of optical and mechanical clot detection for routine coagulation testing in a large volume clinical laboratory.</article-title>
            <source>Blood Coagul Fibrinolysis</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>569</fpage>
            <page-range>569-76</page-range>
            <pub-id pub-id-type="pmid">18685440</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walenga</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Fareed</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Automation and quality control in the coagulation laboratory.</article-title>
            <source>Clin Lab Med</source>
            <year>1994</year>
            <month>Dec</month>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>709</fpage>
            <page-range>709-28</page-range>
            <pub-id pub-id-type="pmid">7874868</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hertzberg</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Mammen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McCraw</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Srivastava</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Achieving and maintaining quality in the laboratory.</article-title>
            <source>Haemophilia</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>12 Suppl 3</volume>
            <fpage>61</fpage>
            <page-range>61-7</page-range>
            <pub-id pub-id-type="pmid">16683998</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ruiz-de-Ch&#x000e1;vez-Ochoa</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>N&#x000fa;&#x000f1;ez-P&#x000e9;rez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mu&#x000f1;oz-Mu&#x000f1;oz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Majluf-Cruz</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>[The quality control in the coagulation laboratory].</article-title>
            <source>Rev Med Inst Mex Seguro Soc</source>
            <year>2008</year>
            <season>May-Jun</season>
            <volume>46</volume>
            <issue>3</issue>
            <fpage>339</fpage>
            <page-range>339-48</page-range>
            <pub-id pub-id-type="pmid">19133213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McFarlane</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Aslan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Raby</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moffat</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Selby</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Padmore</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Internal Quality Control Practices in Coagulation Laboratories: recommendations based on a patterns-of-practice survey.</article-title>
            <source>Int J Lab Hematol</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>37</volume>
            <issue>6</issue>
            <fpage>729</fpage>
            <page-range>729-38</page-range>
            <pub-id pub-id-type="pmid">26108698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Assessment of patient based real-time quality control on comparative assays for common clinical analytes.</article-title>
            <source>J Clin Lab Anal</source>
            <year>2022</year>
            <month>Sep</month>
            <volume>36</volume>
            <issue>9</issue>
            <fpage>e24651</fpage>
            <pub-id pub-id-type="pmid">35949026</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loh</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Bietenbeck</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cervinski</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>van Rossum</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Katayev</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Badrick</surname>
                <given-names>T</given-names>
              </name>
              <collab>International Federation of Clinical Chemistry and Laboratory Medicine Committee on Analytical Quality</collab>
            </person-group>
            <article-title>Recommendation for performance verification of patient-based real-time quality control.</article-title>
            <source>Clin Chem Lab Med</source>
            <year>2020</year>
            <month>Jul</month>
            <day>28</day>
            <volume>58</volume>
            <issue>8</issue>
            <fpage>1205</fpage>
            <page-range>1205-1213</page-range>
            <pub-id pub-id-type="pmid">32049646</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kinns</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pitkin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Housley</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Freedman</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Internal quality control: best practice.</article-title>
            <source>J Clin Pathol</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>66</volume>
            <issue>12</issue>
            <fpage>1027</fpage>
            <page-range>1027-32</page-range>
            <pub-id pub-id-type="pmid">24072731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Westgard</surname>
                <given-names>JO</given-names>
              </name>
            </person-group>
            <article-title>Internal quality control: planning and implementation strategies.</article-title>
            <source>Ann Clin Biochem</source>
            <year>2003</year>
            <month>Nov</month>
            <volume>40</volume>
            <issue>Pt 6</issue>
            <fpage>593</fpage>
            <page-range>593-611</page-range>
            <pub-id pub-id-type="pmid">14629798</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mrazek</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lippi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Keppel</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Felder</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Oberkofler</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Haschke-Becher</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cadamuro</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Errors within the total laboratory testing process, from test selection to medical decision-making - A review of causes, consequences, surveillance and solutions.</article-title>
            <source>Biochem Med (Zagreb)</source>
            <year>2020</year>
            <month>Jun</month>
            <day>15</day>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>020502</fpage>
            <pub-id pub-id-type="pmid">32550813</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ric&#x000f3;s</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Victoria</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>de la Fuente</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Quality indicators and specifications for the extra-analytical phases in clinical laboratory management.</article-title>
            <source>Clin Chem Lab Med</source>
            <year>2004</year>
            <volume>42</volume>
            <issue>6</issue>
            <fpage>578</fpage>
            <page-range>578-82</page-range>
            <pub-id pub-id-type="pmid">15259371</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Badrick</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Integrating quality control and external quality assurance.</article-title>
            <source>Clin Biochem</source>
            <year>2021</year>
            <month>Sep</month>
            <volume>95</volume>
            <fpage>15</fpage>
            <page-range>15-27</page-range>
            <pub-id pub-id-type="pmid">33965412</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smock</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Moser</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>What have we learned from coagulation laboratory participation in external quality programs?</article-title>
            <source>Int J Lab Hematol</source>
            <year>2019</year>
            <month>May</month>
            <volume>41 Suppl 1</volume>
            <fpage>49</fpage>
            <page-range>49-55</page-range>
            <pub-id pub-id-type="pmid">31069983</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De la Salle</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Survey material choices in haematology EQA: a confounding factor in automated counting performance assessment.</article-title>
            <source>Biochem Med (Zagreb)</source>
            <year>2017</year>
            <month>Feb</month>
            <day>15</day>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <page-range>63-72</page-range>
            <pub-id pub-id-type="pmid">28392727</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Della Valle</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Crippa</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Garlando</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Pattarini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Safa</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Vigan&#x000f2; D'Angelo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>D'Angelo</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.</article-title>
            <source>Haematologica</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>84</volume>
            <issue>12</issue>
            <fpage>1065</fpage>
            <page-range>1065-74</page-range>
            <pub-id pub-id-type="pmid">10586206</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kremers</surname>
                <given-names>RMW</given-names>
              </name>
              <name>
                <surname>Zuily</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kelchtermans</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Bloemen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Regnault</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Hemker</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>de Groot</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Wahl</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>de Laat</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Prothrombin conversion is accelerated in the antiphospholipid syndrome and insensitive to thrombomodulin.</article-title>
            <source>Blood Adv</source>
            <year>2018</year>
            <month>Jun</month>
            <day>12</day>
            <volume>2</volume>
            <issue>11</issue>
            <fpage>1315</fpage>
            <page-range>1315-1324</page-range>
            <pub-id pub-id-type="pmid">29895622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hanslik</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Prinseau</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The use of vitamin K in patients on anticoagulant therapy: a practical guide.</article-title>
            <source>Am J Cardiovasc Drugs</source>
            <year>2004</year>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>43</fpage>
            <page-range>43-55</page-range>
            <pub-id pub-id-type="pmid">14967065</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martinuzzo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Barrera</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>D'Adamo</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Otaso</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Do PT and APTT sensitivities to factors' deficiencies calculated by the H47-A2 2008 CLSI guideline reflect the deficiencies found in plasmas from patients?</article-title>
            <source>Int J Lab Hematol</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>37</volume>
            <issue>6</issue>
            <fpage>853</fpage>
            <page-range>853-60</page-range>
            <pub-id pub-id-type="pmid">26338156</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gosselin</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Marlar</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Preanalytical Variables in Coagulation Testing: Setting the Stage for Accurate Results.</article-title>
            <source>Semin Thromb Hemost</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>45</volume>
            <issue>5</issue>
            <fpage>433</fpage>
            <page-range>433-448</page-range>
            <pub-id pub-id-type="pmid">31291676</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lippi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Favaloro</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Preanalytical Issues in Hemostasis and Thrombosis Testing.</article-title>
            <source>Methods Mol Biol</source>
            <year>2017</year>
            <volume>1646</volume>
            <fpage>29</fpage>
            <page-range>29-42</page-range>
            <pub-id pub-id-type="pmid">28804816</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adcock Funk</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Lippi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Favaloro</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Quality standards for sample processing, transportation, and storage in hemostasis testing.</article-title>
            <source>Semin Thromb Hemost</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>38</volume>
            <issue>6</issue>
            <fpage>576</fpage>
            <page-range>576-85</page-range>
            <pub-id pub-id-type="pmid">22706973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haripersadh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pillay</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rapiti</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Impact of rapid centrifugation on routine coagulation assays in South Africa.</article-title>
            <source>Afr J Lab Med</source>
            <year>2022</year>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>1901</fpage>
            <pub-id pub-id-type="pmid">36483324</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gosselin</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Honeychurch</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Dwyre</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Effect of Multiple Freeze-Thaw Cycles on Coagulation Testing.</article-title>
            <source>Semin Thromb Hemost</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>46</volume>
            <issue>4</issue>
            <fpage>515</fpage>
            <page-range>515-520</page-range>
            <pub-id pub-id-type="pmid">32438422</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hellenbart</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Faulkenberg</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Finks</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of bleeding in patients receiving direct oral anticoagulants.</article-title>
            <source>Vasc Health Risk Manag</source>
            <year>2017</year>
            <volume>13</volume>
            <fpage>325</fpage>
            <page-range>325-342</page-range>
            <pub-id pub-id-type="pmid">28860793</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27892.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HK</given-names>
              </name>
            </person-group>
            <article-title>Influence of blood lipids on global coagulation test results.</article-title>
            <source>Ann Lab Med</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>15</fpage>
            <page-range>15-21</page-range>
            <pub-id pub-id-type="pmid">25553275</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
